Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Efsubaglutide Alfa

The Efficacy and Safety of Efsubaglutide Alfa in Overweight/Obesity(SPARKLE)

Shanghai Yinnuo Pharmaceutical Technology Co · Phase 2 · Recruiting · Enrollment 200

NCT07114419

ArmPopulationDoseWeeksEstimandWeight change
Efsubaglutide 20 mg Quaque Week (QW)Obesity or overweight20 mg2n/rn/r
Efsubaglutide 40 mg QWObesity or overweight40 mg2n/rn/r
Efsubaglutide Alfa 40 mg Q2WObesity or overweight40 mg2n/rn/r
Efsubaglutide Alfa 80 mg QWObesity or overweight80 mg2n/rn/r
Efsubaglutide Alfa 80 mg Q4WObesity or overweight80 mg2n/rn/r